Search results for "Atrial fibrillation"
Atrial fibrillation rates rose even more than predicted
There may have been 10.55 million U.S. adults diagnosed with atrial fibrillation (AF) in 2019, exceeding predictions from previous decades, according to an analysis of all patients treated in California.
https://immattersacp.org/weekly/archives/2024/09/17/1.htm
17 Sep 2024
Afib guideline updates diagnosis, management strategies
An updated guideline from cardiology societies places new emphasis on lifestyle and risk factor modification in patients with atrial fibrillation and risk for recurrence when afib occurs after surgery, among other changes.
https://immattersacp.org/weekly/archives/2023/12/12/4.htm
12 Dec 2023
Patch monitor screening for atrial fibrillation may be cost-effective in high-risk patients
Wearing patch monitors for two weeks of atrial fibrillation screening provided economic value in gained quality-adjusted life-years for high-risk older patients, according to a new analysis of a randomized trial.
https://immattersacp.org/weekly/archives/2023/11/07/4.htm
7 Nov 2023
1 in 3 adults with new-onset afib during hospitalization have recurrence within a year
The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.
https://immattersacp.org/weekly/archives/2023/10/03/1.htm
3 Oct 2023
Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
Point-of-care screening did not affect diagnosis of afib in primary care, study finds
In a randomized trial at 16 primary care clinics in Massachusetts, rates of new afib diagnosis at one year were 1.72% with afib screening of older patients using a single-lead electrocardiogram versus 1.59% with usual care.
https://immattersacp.org/weekly/archives/2022/03/08/1.htm
8 Mar 2022
Task Force finds insufficient evidence on screening for afib
The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.
https://immattersacp.org/weekly/archives/2022/02/01/3.htm
1 Feb 2022
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
DOACs associated with lower risk of fracture than warfarin in atrial fibrillation
Patients taking apixaban, dabigatran, or rivaroxaban had lower rates of hip and vertebral fractures than those taking warfarin, with no difference seen between the direct oral anticoagulants (DOACs).
https://immattersacp.org/weekly/archives/2020/05/19/2.htm
19 May 2020
Dual therapy for afib after PCI may reduce bleeding risk better than triple therapy
Researchers reviewed four randomized controlled trials of 7,953 patients that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events after percutaneous coronary intervention (PCI).
https://immattersacp.org/weekly/archives/2020/03/17/4.htm
17 Mar 2020
Apixaban may be safer, more effective than rivaroxaban for afib
Patients taking rivaroxaban had higher rates of stroke or systemic embolism and gastrointestinal or brain bleeding compared to those taking apixaban, according to a retrospective cohort study.
https://immattersacp.org/weekly/archives/2020/03/10/4.htm
10 Mar 2020
Intervention targeting clinicians did not increase anticoagulation use in patients with afib
Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
https://immattersacp.org/weekly/archives/2020/02/25/4.htm
25 Feb 2020
Alcohol abstinence may reduce secondary atrial fibrillation, randomized trial finds
An editorial noted the potential difficulty of convincing patients who drink regularly to abstain from alcohol long enough to make a difference.
https://immattersacp.org/weekly/archives/2020/01/07/2.htm
7 Jan 2020
Catheter ablation improved quality of life, but not major adverse cardiac events, versus medical therapy in afib
This research provides essential information to optimize the care of atrial fibrillation patients in a patient-centric way that allows for shared decision making when considering treatment options, an editorial noted.
https://immattersacp.org/weekly/archives/2019/03/19/2.htm
19 Mar 2019
ACP offers free webinar on atrial fibrillation stroke prevention on March 6
Attendees will learn how to effectively assess at-risk patients, discuss the relationship between atrial fibrillation and stroke, and discuss effective prevention strategies.
https://immattersacp.org/weekly/archives/2019/02/12/5.htm
12 Feb 2019
NOACs recommended instead of warfarin for some afib patients, guideline states
An updated guideline on atrial fibrillation responds to new evidence, as well as the advent of new drugs and devices to treat the condition.
https://immattersacp.org/weekly/archives/2019/02/05/2.htm
5 Feb 2019